A Review of the Dermatological Complications of Giant Cell Arteritis

References

• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–1461. doi:10.1002/art.24459
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–271. doi:10.1056/NEJMra011913
   PubMed Web of Science ®Google Scholar
• Carmona FD, González-Gay MA, Martín J. Genetic component of giant cell arteritis. Rheumatol Oxf Engl. 2014;53:6–18. doi:10.1093/rheumatology/ket231
   PubMed Web of Science ®Google Scholar
• Carmona FD, Mackie SL, J-e M, et al. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet. 2015;96:565–580. doi:10.1016/j.ajhg.2015.02.009
   PubMed Web of Science ®Google Scholar
• Prieto-Peña D, Remuzgo-Martínez S, Ocejo-Vinyals JG, et al. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. Semin Arthritis Rheum. 2020;50(5):897–901. doi:10.1016/j.semarthrit.2020.07.004
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med. 2002;69(Suppl 2):SII28–SII32.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Goronzy JJ, Berry G, Liao YJ, Weyand CM. Giant cell arteritis: from pathogenesis to therapeutic management. Curr Treat Options Rheumatol. 2016;2:126–137. doi:10.1007/s40674-016-0043-x
   Google Scholar
• Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine. 2005;84:269–276. doi:10.1097/01.md.0000180042.42156.d1
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Castañeda S, Llorca J. Giant cell arteritis: visual loss is our major concern. J Rheumatol. 2016;43:1458–1461. doi:10.3899/jrheum.160466
   PubMed Web of Science ®Google Scholar
• González-Gay MA, García-Porrúa C, Llorca J, et al. Visual manifestations of giant cell arteritis trends and clinical spectrum in 161 patients. Medicine. 2000;79:283–292.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine. 2009;88:227–235. doi:10.1097/MD.0b013e3181af4518
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet Lond Engl. 2017;390:1700–1712. doi:10.1016/S0140-6736(17)31825-1
   PubMed Web of Science ®Google Scholar
• Prieto-Peña D, Martínez-Rodríguez I, Loricera J, et al. Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. Semin Arthritis Rheum. 2019;48:720–727. doi:10.1016/j.semarthrit.2018.05.007
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Prieto-Peña D, Calderón-Goercke M, Atienza-Mateo B, Castañeda S. Giant cell arteritis: more than a cranial disease. Clin Exp Rheumatol. 2020;38(Suppl 124):15–17.
   Google Scholar
• González-Gay MA, Prieto-Peña D, Martínez-Rodríguez I, et al. Early large vessel systemic vasculitis in adults. Best Pract Res Clin Rheumatol. 2019;33:101424. doi:10.1016/j.berh.2019.06.006
   PubMed Web of Science ®Google Scholar
• Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72:1989–1994. doi:10.1136/annrheumdis-2012-202408
   PubMed Web of Science ®Google Scholar
• Baum EW, Sams WM, Payne RR. Giant cell arteritis: a systemic disease with rare cutaneous manifestations. J Am Acad Dermatol. 1982;6:1081–1088. doi:10.1016/S0190-9622(82)70094-5
   PubMed Web of Science ®Google Scholar
• Chasset F, Francès FC. Cutaneous manifestations of medium- and large-vessel vasculitis. Clin Rev Allergy Immunol. 2017;53:452–468. doi:10.1007/s12016-017-8612-9
   PubMed Web of Science ®Google Scholar
• Kinmont PD, Mccallum DI. SKIN MANIFESTATIONS OF GIANT-CELL ARTERITIS. Br J Dermatol. 1964;76:299–308. doi:10.1111/j.1365-2133.1964.tb14533.x
   Web of Science ®Google Scholar
• Martinez-Lado L, Calviño-Díaz C, Piñeiro A, et al. Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine (Baltimore). 2011;90:186–193. doi:10.1097/MD.0b013e31821c4fad
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Pina T, Prieto-Peña D, Calderon-Goercke M, Blanco R, Castañeda S. Current and emerging diagnosis tools and therapeutics for giant cell arteritis. Expert Rev Clin Immunol. 2018;14:593–605. doi:10.1080/1744666X.2018.1485491
   PubMed Web of Science ®Google Scholar
• Cooke WT, Cloake PCP, Govan ADT, Colbeck JC. Temporal arteritis: a generalized vascular disease. Q J Med. 1946;15:47–75. doi:10.1093/qjmed/15.57.47
   PubMedGoogle Scholar
• Soderstrom CW, Seehafer JR. Bilateral scalp necrosis in temporal arteritis. A rare complication of Horton’s disease. Am J Med. 1976;61:541–546. doi:10.1016/0002-9343(76)90335-1
   Web of Science ®Google Scholar
• Tsianakas A, Ehrchen JM, Presser D, et al. Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis. J Am Acad Dermatol. 2009;61:701–706. doi:10.1016/j.jaad.2008.11.913
   Web of Science ®Google Scholar
• Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100:193–196. doi:10.1016/S0002-9343(97)89458-2
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997;24:2171–2176.
   Web of Science ®Google Scholar
• Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatol Oxf Engl. 2001;40:1238–1242. doi:10.1093/rheumatology/40.11.1238
   PubMed Web of Science ®Google Scholar
• Idoudi S, Ben Kahla M, Mselmi F, et al. Scalp necrosis revealing severe giant-cell arteritis. Case Rep Med. 2020;2020:8130404. doi:10.1155/2020/8130404
   Web of Science ®Google Scholar
• Akram Q, Knight S, Saravanan R. Bilateral scalp necrosis as a rare but devastating complication of giant cell arteritis. Clin Rheumatol. 2015;34:185–187. doi:10.1007/s10067-014-2792-y
   Web of Science ®Google Scholar
• Henderson AH. Tongue pain with giant cell arteritis. Br Med J. 1967;4:337. doi:10.1136/bmj.4.5575.337
   Web of Science ®Google Scholar
• Grant SWJ, Underhill HC, Atkin P. Giant cell arteritis affecting the tongue: a case report and review of the literature. Dent Update. 2013;40:669–70,673–4, 677. doi:10.12968/denu.2013.40.8.669
   Google Scholar
• Grahame R, Bluestone R, Holt PJ. Recurrent blanching of the tongue due to giant cell arteritis. Ann Intern Med. 1968;69:781–782. doi:10.7326/0003-4819-69-4-781
   Web of Science ®Google Scholar
• Reed C, Inlis MJ. Acute massive gangrene of tongue. Br Med J. 1965;2:575–576. doi:10.1136/bmj.2.5461.575
   Web of Science ®Google Scholar
• Sobrinho RA, de Lima KC, Moura HC, et al. Tongue necrosis secondary to giant cell arteritis: a case report and literature review. Case Rep Med. 2017;2017:1–5. doi:10.1155/2017/6327437
   Web of Science ®Google Scholar
• Pogrel MA. Necrosis of the upper lip from giant-cell arteritis. J Oral Maxillofac Surg off. 1985;43:300–302. doi:10.1016/0278-2391(85)90294-0
   Web of Science ®Google Scholar
• Kumar R, Gupta H, Jadhav A, Khadilkar S. Bitemporal scalp, lip and tongue necrosis in giant cell arteritis: a rare presentation. Indian J Dermatol. 2013;58:328. doi:10.4103/0019-5154.113980
   Google Scholar
• Zaragoza JR, Vernon N, Ghaffari G. Tongue necrosis as an initial manifestation of giant cell arteritis: case report and review of the literature. Case Rep Rheumatol. 2015;2015. doi:10.1155/2015/901795
   Google Scholar
• Vivancos J, Bosch X, López-Soto A, Font J, Ribera JM, Ingelmo M. Giant cell arteritis presenting as a supraclavicular nodule. Ann Rheum Dis. 1990;49:202–203. doi:10.1136/ard.49.3.202-c
   PubMed Web of Science ®Google Scholar
• Waugh TR. Bilateral mammary arteritis; report of a case. Am J Pathol. 1950;26:851–861.
   Web of Science ®Google Scholar
• Potter BT, Housley E, Thomson D. Giant-cell arteritis mimicking carcinoma of the breast. Br Med J Clin Res Ed. 1981;282:1665–1666. doi:10.1136/bmj.282.6277.1665
   Web of Science ®Google Scholar
• Stephenson TJ, Underwood JC. Giant cell arteritis: an unusual cause of palpable masses in the breast. Br J Surg. 1986;73:105. doi:10.1002/bjs.1800730208
   Web of Science ®Google Scholar
• Cook DJ, Bensen WG, Carroll JJ, Joshi S. Giant cell arteritis of the breast. CMAJ Can Med Assoc J J Assoc Medicale Can. 1988;139:513–515.
   Web of Science ®Google Scholar
• McKendry RJ, Guindi M, Hill DP. Giant cell arteritis (temporal arteritis) affecting the breast: report of two cases and review of published reports. Ann Rheum Dis. 1990;49:1001–1004. doi:10.1136/ard.49.12.1001
   PubMed Web of Science ®Google Scholar
• Meriglier E, Belhadj Chaidi R, Debouverie O, Luca L, Roblot P. Pseudo-tumeurs mammaires révélant une maladie de Horton. [Breast lesions as the presenting feature of giant cell arteritis]. Rev Med Interne. 2016;37:561–563. doi:10.1016/j.revmed.2015.09.005.French.
   Web of Science ®Google Scholar
• Tabbarah A, Voltaggio L. Giant cell arteritis of the breast. Arch Pathol Lab Med. 2017;141:1283–1287. doi:10.5858/arpa.2016-0285-RS
   Web of Science ®Google Scholar
• Goldberg JW, Lee ML, Sajjad SM. Giant cell arteritis of the skin simulating erythema nodosum. Ann Rheum Dis. 1987;46:706–708. doi:10.1136/ard.46.9.706
   PubMed Web of Science ®Google Scholar
• Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014;20:22376.
   PubMedGoogle Scholar
• Fukai K, Ishii M, Kobayashi H, Someda Y, Hamada T, Tsujino S. Generalized granuloma annulare in a patient with temporal arteritis–are these conditions associated? Clin Exp Dermatol. 1990;15:70–72. doi:10.1111/j.1365-2230.1990.tb02027.x
   PubMed Web of Science ®Google Scholar
• Yáñez S, Val-Bernal JF, Peña-Sagredo JL, Jiménez-Gómez I, Vazquez-Rodriguez TR, Gonzalez-Gay MA. Generalized granuloma annulare and giant cell arteritis. Clin Exp Rheumatol. 2008;26:S108–S110.
   Web of Science ®Google Scholar
• Shoimer I, Wismer J. Annular elastolytic giant cell granuloma associated with temporal arteritis leading to blindness. J Cutan Med Surg. 2011;15:293–297. doi:10.2310/7750.2011.10042
   Web of Science ®Google Scholar
• Kluger N, Riviere S, Mura F, Guillot B, Girard C. Simultaneous occurrence of generalized granuloma annulare, anterior uveitis and giant cell arteritis: coincidental or not? Presse Medicale. 2011;41:548–549. doi:10.1016/j.lpm.2011.08.006
   Web of Science ®Google Scholar
• Torisu Y, Horai Y, Michitsuji T, et al. Giant cell arteritis with generalized granuloma annulare. Intern Med Tokyo Jpn. 2019;58:1173–1177. doi:10.2169/internalmedicine.1978-18
   Web of Science ®Google Scholar
• Middleton D, Allen GE. HLA antigen frequency in granuloma annulare. Br J Dermatol. 1984;110:57–59. doi:10.1111/j.1365-2133.1984.tb07312.x
   Web of Science ®Google Scholar
• Gonzalez-Gay MA, Rueda B, Vilchez JR, et al. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatol Oxf Engl. 2007;46:431–434. doi:10.1093/rheumatology/kel324
   Web of Science ®Google Scholar
• Piette EW, Rosenbach M. Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol. 2016;75:457–465. doi:10.1016/j.jaad.2015.03.054
   Web of Science ®Google Scholar
• Dabski K, Winkelmann RK. Generalized granuloma annulare: clinical and laboratory findings in 100 patients. J Am Acad Dermatol. 1989;20:39–47. doi:10.1016/S0190-9622(89)70005-0
   PubMed Web of Science ®Google Scholar
• Nordmann TM, Kim J-R, Dummer R, Anzengruber F, Monocentric A. Retrospective analysis of 61 patients with generalized granuloma annulare. Dermatol Basel Switz. 2020;236:369–374. doi:10.1159/000507247
   Web of Science ®Google Scholar
• Hanna WM, Moreno-Merlo F, Andrighetti L. Granuloma annulare: an elastic tissue disease? Case report and literature review. Ultrastruct Pathol. 1999;23:33–38. doi:10.1080/019131299281815
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol. 2007;25:S52–S56.
   Web of Science ®Google Scholar
• Gonzalez-Gay MA, Lopez-Diaz MJ, Martinez-Lado L, et al. Cancer in biopsy-proven giant cell arteritis. A population-based study. Semin Arthritis Rheum. 2007;37:156–163. doi:10.1016/j.semarthrit.2007.03.006
   PubMed Web of Science ®Google Scholar
• Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002;29:2143–2147.
   PubMed Web of Science ®Google Scholar
• Kermani TA, Schäfer VS, Crowson CS, et al. Malignancy risk in patients with giant cell arteritis: a population-based cohort study. Arthritis Care Res. 2010;62:149–154.
   Web of Science ®Google Scholar
• Hill CL, Cole A, Rischmueller M, et al. Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatol Oxf Engl. 2010;49:756–759. doi:10.1093/rheumatology/kep409
   Web of Science ®Google Scholar
• LeBoit PE, Davis-Reed L. Light microscopy: clues to systemic disease in reexcision specimens of basal cell carcinoma. Am J Dermatopathol. 1999;21:361–364. doi:10.1097/00000372-199908000-00009
   Web of Science ®Google Scholar
• Mahe E, Demellawy DE, Bane A, Alowami S. Giant cell temporal arteritis associated with overlying basal cell carcinoma: co-incidence or connection? Rare Tumors. 2012;4:e46. doi:10.4081/rt.2012.e46
   Google Scholar
• Gonzalez-Gay MA. The diagnosis and management of patients with giant cell arteritis. J Rheumatol. 2005;32:1186–1188.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–643. doi:10.1136/annrheumdis-2017-212649
   PubMed Web of Science ®Google Scholar
• Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–1128. doi:10.1002/art.1780330810
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, et al. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine. 2005;84:277–290. doi:10.1097/01.md.0000180043.19285.54
   PubMed Web of Science ®Google Scholar
• Hellmich B, Agueda A, Monti S, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79:19–30.
   PubMed Web of Science ®Google Scholar
• González-Gay MÁ, Pina T, Prieto-Peña D, Calderon-Goercke M, Gualillo O, Castañeda S. Treatment of giant cell arteritis. Biochem Pharmacol. 2019;165:230–239.
   PubMed Web of Science ®Google Scholar
• Mahr AD, Jover JA, Spiera RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum. 2007;56:2789–2797. doi:10.1002/art.22754
   PubMed Web of Science ®Google Scholar
• Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317–328. doi:10.1056/NEJMoa1613849
   PubMed Web of Science ®Google Scholar
• Loricera J, Blanco R, Hernández JL, et al. Tocilizumab in giant cell arteritis: multicenter open-label study of 22 patients. Semin Arthritis Rheum. 2015;44:717–723. doi:10.1016/j.semarthrit.2014.12.005
   PubMed Web of Science ®Google Scholar
• Calderón-Goercke M, Loricera J, Aldasoro V, et al. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice. Semin Arthritis Rheum. 2019;49:126–135. doi:10.1016/j.semarthrit.2019.01.003
   PubMed Web of Science ®Google Scholar